Niazi, I., Bahnson, T. D., Lanzerotti, C., McPike, J., Kiemen, J., Kappel, D., … Wolff, A. A. (2001). Termination of supraventricular tachycardia with CVT-510, a selective A1 adenosine receptor agonist, is associated with fewer arrhythmias than adenosine. In CIRCULATION (Vol. 104, pp. 489–489). LIPPINCOTT WILLIAMS & WILKINS.

Niazi, I., T. D. Bahnson, C. Lanzerotti, J. McPike, J. Kiemen, D. Kappel, L. Belardinelli, J. Cheng, R. Shreeniwas, and A. A. Wolff. “Termination of supraventricular tachycardia with CVT-510, a selective A1 adenosine receptor agonist, is associated with fewer arrhythmias than adenosine.” In CIRCULATION, 104:489–489. LIPPINCOTT WILLIAMS & WILKINS, 2001.

Niazi I, Bahnson TD, Lanzerotti C, McPike J, Kiemen J, Kappel D, et al. Termination of supraventricular tachycardia with CVT-510, a selective A1 adenosine receptor agonist, is associated with fewer arrhythmias than adenosine. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2001. p. 489–489.

Niazi, I., et al. “Termination of supraventricular tachycardia with CVT-510, a selective A1 adenosine receptor agonist, is associated with fewer arrhythmias than adenosine.” CIRCULATION, vol. 104, no. 17, LIPPINCOTT WILLIAMS & WILKINS, 2001, pp. 489–489.

Niazi I, Bahnson TD, Lanzerotti C, McPike J, Kiemen J, Kappel D, Belardinelli L, Cheng J, Shreeniwas R, Wolff AA. Termination of supraventricular tachycardia with CVT-510, a selective A1 adenosine receptor agonist, is associated with fewer arrhythmias than adenosine. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2001. p. 489–489.